![](/fileadmin/_processed_/csm_tme_eisberg_illu_cxcl12_56348618ca.jpg)
TME Pharma gets FDA Fast Track for Glioblastoma
TME Pharma N.V. with research sites in France and Germany (listed at Euronext Growth Paris: ALTME) is developing novel therapies for treatment of...
![](/fileadmin/_processed_/csm_Obstructive_Sleep_Apnea_Treatment_Genio_by_Nyxoah_083756dfdb.png)
Nyxoah signs a €37.5m loan with the European Investment Bank
Nyxoah SA (Euronext Brussels/Nasdaq: NYXH), located in Mont-Saint-Guibert, Belgium announced that it has signed a €37.5m loan facility agreement with...
![](/fileadmin/_processed_/csm_Biotalys_platform_b35a9cfabc.png)
Biotalys starts field testing for biofungicide
The protein-based biofungicide is under development of the company’s Agrobody technology platform for sustainable biocontrols as an alternative...
![](/fileadmin/_processed_/csm_puppy-1207816_1280_b8d31894a0.jpg)
First dog snack from microbial protein
Single cell protein specialist MicroHarvest GmbH is set to co-develop the very first pet feed reducing the carbon dioxide pawprint of dogs in...
![](/fileadmin/_processed_/csm_EB224_ECC03_tg_4a0c378aa9.png)
Full house at European Cluster Conference
Compared to the USA and China, EU biotech clusters appear to be dwarfed by the lack of industry-specific support in terms of access to funding,...
![](/fileadmin/_processed_/csm_dollars-499481_1280-_Gerd_Altmann_pixabay_55a91b9ae7.jpg)
Forbion closes first Bioeconomy Fund with US$75m
Life Science investor Forbion opens a new sector for its lead partners who were eager to put money into industries within the ESG standards. At...
![](/fileadmin/_processed_/csm_valneva_lab-web-STA_3217-scaled_e65f26fc69.jpg)
Valneva gets approval for Chikungunya vaccine in Canada
Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) announced today that Health Canada has approved IXCHIQ®, Valneva's single-dose vaccine for the...